Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy

Veterinary Radiology and Ultrasound

Volumn 51, Issue 5, 2010, Pages 561-570

  Lawrence, Jessica A ^a,e   Forrest, Lisa J ^b,c   Turek, Michelle M ^b,e   Miller, Paul E ^b   Mackie, T Rockwell ^c,d   Jaradat, Hazim A ^c   Vail, David M ^a,c   Dubielzig, Richard R ^b   Chappell, Richard ^c   Mehta, Minesh P ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Department of Surgical Sciences ^*  (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d TOMOTHERAPY INC   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

Canine; Ocular sparing; Oncology; Radiation therapy; Tomotherapy; Toxicity

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CANCER STAGING; CARCINOMA; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DOG; DOG DISEASE; INTENSITY MODULATED RADIATION THERAPY; METHODOLOGY; PARANASAL SINUS TUMOR; PATHOLOGY; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; SARCOMA;

ANIMALS; CARCINOMA; DOG DISEASES; DOGS; NEOPLASM STAGING; PARANASAL SINUS NEOPLASMS; PATIENT SELECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SARCOMA;

CANIS FAMILIARIS;

EID: 77956324189     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2010.01695.x     Document Type: Article

References (55)

1. Mackie TR, Balog J, Ruchala K. Tomotherapy. Semin Radiat Oncol 1999, 9:108-117.
2. Mackie TR, Kapatoes J, Ruchala K. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003, 56:89-105.
3. Beavis AW. Is tomotherapy the future of IMRT? Br J Radiol 2004, 77:285-295.
4. Adams WM, Bjorling DE, McAnulty JE. Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases (1990-2002). J Am Vet Med Assoc 2005, 227:396-341.
5. Adams WM, Miller PE, Vail DM. An accelerated technique for irradiation of malignant canine nasal and paranasal sinus tumors. Vet Radiol Ultrasound 1998, 39:475-481.
6. Adams WM, Withrow SJ, Walshaw R. Radiotherapy of malignant nasal tumors in 67 dogs. J Am Vet Med Assoc 1987, 191:311-315.
7. McEntee MC, Page RL, Heidner GL. A retrospective study of 27 dogs with intranasal neoplasms treated with cobalt radiation. Vet Radiol 1991, 32:135-139.
8. Theon AP, Madewell BR, Harb MF. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. J Am Vet Med Assoc 1993, 202:1469-1475.
9. Thrall DE, Harvey CE. Radiotherapy of malignant nasal tumors in 21 dogs. J Am Vet Med Assoc 1983, 183:663-666.
10. Thrall DE, Heidner GL, Novotney CA. Failure patterns following cobalt irradiation in dogs with nasal carcinoma. Vet Radiol Ultrasound 1993, 34:126-133.
11. Rassnick KM, Goldkamp CE, Erb HN. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003). J Am Vet Med Assoc 2006, 229:401-406.
12. Claus F, Boterberg T, Ost P. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol 2002, 64:205-208.
13. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys 1995, 31:1123-1139.
14. Hemple M, Hinkelbein W. Eye sequelae following external irradiation. Recent Results Cancer Res 1993, 130:231-236.
15. Jiang GL, Tucker SL, Guttenberger R. Radiation-induced injury to the visual pathway. Radiother Oncol 1994, 30:17-25.
16. Parsons JT, Bova FJ, Fitzgerald CR. Severe dry-eye syndrome following external beam irradiation. Int J Radiat Onocol Biol Phys 1994, 30:775-780.
17. Ching SV, McChesney-Gillette S, Powers BE. Radiation-induced ocular injury in the dog: a histological study. Int J Radiat Oncol Biol Phys 1990, 19:321-328.
18. Jamieson VE, Davidson MG, Nasisse MP. Ocular complications following cobalt 60 radiotherapy of neoplasms in the canine head region. J Am Anim Hosp Assoc 1991, 27:51-55.
19. Roberts SM, Lavach JD, Severin GA. Ophthalmic complications following megavoltage irradiation of the nasal and paranasal cavities in dogs. J Am Vet Med Assoc 1987, 190:43-47.
20. Green EM, Adams WM, Forrest LJ. Accelerated radiotherapy for canine nasal neoplasia, 2002 Annual Scientific Meeting of the American College of Veterinary Radiology. Chicago, IL. Vet Radiol Ultrasound 2003, 44:113.
21. Drees R, Forrest LJ, Chappell R. Comparison of computed tomography and magnetic resonance imaging for evaluation of canine intranasal neoplasia. J Small Anim Pract 2009, 50:334-340.
22. Forrest LJ, Lawrence JA, Miller PE. Ocular sparing using image-guided helical tomotherapy (IGHT) in spontaneous sino-nasal tumors in dogs #2387. Int J Radiat Oncol Biol Phys 2006, 66:S452.
23. Forrest LJ, Mackie TR, Ruchala K. The utility of megavoltage computed tomography images from a helical tomotherapy system for set-up verification purposes. Int J Radiat Oncol Biol Phys 2004, 60:1639-1644.
24. Therasse P, Arbuck SG, Eisenhauer EA. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
25. Cox DR, Oakes D. Analysis of survival data 1984, London, Chapman and Hall
26. Miller PE, Murphy C. Vision in dogs. J Am Vet Med Assoc 1995, 207:1623-1634.
27. Adams EJ, Nutting CM, Convery DJ. Potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus. Int J Radiat Oncol Biol Phys 2001, 51:579-588.
28. Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 2001, 96:126-131.
29. Clark CH, Bidmead AM, Mubata CD. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 2004, 70:189-198.
30. Cozzi L, Fogliata A, Bolsi A. Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys 2004, 58:617-624.
31. Huang D, Xia P, Akazawa P. Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:158-168.
32. Kam MK, Chau RM, Suen J. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003, 56:145-157.
33. Mock U, Georg D, Bogner J. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:147-154.
34. Nutting CM, Convery DJ, Cosgrove VP. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 2001, 60:173-180.
35. Blanco AI, Chao KS, El Naqa I. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:1055-1069.
36. Chao KS, Ozyigit G, Blanco AI. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 2004, 59:43-50.
37. Jabbari S, Kim HM, Feng M. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 2005, 63:725-731.
38. Munter MW, Karger CP, Hoffner SG. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 2004, 58:174-184.
39. Parliament MB, Scrimger RA, Anderson SG. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004, 58:663-673.
40. Butler EB, Teh BS, Grant WHR. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999, 45:21-32.
41. Claus F, Boterberg T, Ost P. Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: treatment results for 47 patients. Int J Radiat Oncol Biol Phys 2002, 54:1089-1094.
42. Lu TX, Mai WY, Teh BS. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:682-687.
43. Madani I, Bonte K, Vakaet L. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009, 73:424-432.
44. Teh BS, Amosson CM, Mai WY. Intensity modulated radiation therapy (IMRT) in the management of prostate cancer. Cancer Invest 2004, 22:913-924.
45. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51:880-914. Group IMRTCW
46. Welsh JS, Patel RR, Ritter MA. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat 2002, 1:311-316.
47. Zelefsky MJ, Fuks Z, Hunt M. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
48. Lee AW, Poon YF, Foo W. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992, 23:261-270.
49. Teo PM, Yu P, Lee WY. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996, 36:291-304.
50. Yan JH, Xu GZ, Hu YH. Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trail on booster dose. Int J Radiat Oncol Biol Phys 1990, 18:295-298.
51. Chang SD, Tate DJ, Gofinet DR. Treatment of nasopharyngeal carcinoma: stereotactic radiosurgical boost following fractionated radiotherapy. Sterotact Funct Neurosurg 1999, 73:64-67.
52. Chau RM, Teo PM, Choi PH. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol 2001, 58:143-153.
53. Deveau MA, Gutierrez AN, Mackie TR. Dosimetric impact of daily setup variations during treatment of canine nasal tumors using intensity-modulated radiation therapy. Vet Radiol Ultrasound 2010, 51:90-96.
54. Welsh JS, Lock M, Harari PM. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat 2006, 5:465-479.
55. Gutíerrez AN, Deveau MA, Forrest LJ. Radiobiological and treatment planning study of a simultaneously integrated boost for canine nasal tumors using helical tomotherapy. Vet Radiol Ultrasound 2007, 48:594-602.